Por favor, use este identificador para citar o enlazar este ítem:
http://repositorio.uan.edu.co/handle/123456789/2342Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.advisor | Reyes Clavijo, Ligia Soraya | - |
| dc.contributor.advisor | Marín Ballesteros, Diana Milena | - |
| dc.creator | Romero Chia, Ana Daniela | - |
| dc.date.accessioned | 2021-03-02T22:19:04Z | - |
| dc.date.available | 2021-03-02T22:19:04Z | - |
| dc.date.created | 2020-11-15 | - |
| dc.identifier.uri | http://repositorio.uan.edu.co/handle/123456789/2342 | - |
| dc.description | Propia | es_ES |
| dc.description.abstract | Glaucoma is the second leading cause of blindness in the world, its main risk factor is the increase in intraocular pressure causing damage to the optic nerve and also affecting the visual field, the prevalence of glaucoma increases in people over 60 years of age, therefore, detection and proper treatment are required to prevent the progression of this disease. Objective: To analyze the strategies and aspects of public health that can decrease the prevalence of glaucoma as a visual disability. Methodology: A bibliographic review was performed in different databases using Mesh terms. Results: It was evidenced that the countries with the lowest prevalence of glaucoma are Australia, Japan and Saudi Arabia, since in each of these there are promotion and prevention strategies obtaining good results in terms of glaucoma management, it was also evidenced that there are policies in Colombia promotion and prevention against glaucoma but a restructuring of these is necessary, mainly in terms of the training of optometrists, high-tech clinical equipment, updating of drugs for the treatment of glaucoma. | es_ES |
| dc.description.sponsorship | UAN Proyectos de ciencia, tecnología, innovación y creación artística | es_ES |
| dc.description.tableofcontents | El glaucoma es la segunda causa de ceguera en el mundo, su principal factor de riesgo es el aumento de la presión intraocular provocando un daño en el nervio óptico y afectando también el campo visual, la prevalencia del glaucoma aumenta en personas mayores de 60 años, por ello se requiere la detección y un debido tratamiento para evitar el progreso de esta enfermedad. Objetivo: Analizar las estrategias y aspectos de salud pública que pueden disminuir las secuelas que genera el glaucoma ya que conlleva a la discapacidad visual. Metodología: se realizó una revisión bibliográfica en diferentes bases de datos utilizando términos Mesh. Resultados: Se evidencio que los países con menor prevalencia de glaucoma son Australia, Japón y Arabia Saudita ya que en cada uno de estos existen estrategias de promoción y prevención obteniendo buenos resultados en cuanto al manejo del glaucoma, también se evidenció que en Colombia hay políticas de promoción y prevención frente al glaucoma pero se hace necesaria una reestructuración de estas principalmente en cuanto a la capacitación de los optómetras, equipos clínicos de alta tecnología, actualización de medicamentos para el tratamiento del glaucoma. | es_ES |
| dc.language.iso | spa | es_ES |
| dc.publisher | Universidad Antonio Nariño | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| dc.subject | Glaucoma, Prevalencia, Salud pública, Población. | es_ES |
| dc.title | Glaucoma: un reto para la salud publica | es_ES |
| dc.publisher.program | Optometría | es_ES |
| dc.rights.accesRights | openAccess | es_ES |
| dc.subject.keyword | Glaucoma, Prevalence, Public health, Population. | es_ES |
| dc.type.spa | Trabajo de grado (Pregrado y/o Especialización) | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/acceptedVersion | es_ES |
| dc.source.bibliographicCitation | 1.National Council of Ophthalmology. International Council of Ophthalmology (ICO) Guidelines for Glaucoma [Internet]. 2016 [cited 2020 Mar 13]. Available from: http://www.icoph.org/downloads/ICOGlaucomaGuidelines-Spanish.pdf 2. WHO launches first Global Vision Report [Internet]. OMS. 2019 [cited 2020 Mar 23]. p. 1. Available from: https://www.who.int/es/news-room/detail/08-10-2019-who-launches-first-world-report-on-vision 3. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014 Nov 1;121(11):2081–90. 4. Bernal GB, General S. Visual health situation analysis in Colombia [Internet]. 2016 [cited 2020 Mar 13]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/asis-salud-visual-colombia-2016.pdf 5. Bernal GB, General S, Gómez FR, Valderrama JF. National Visual Health Program in Colombia [Internet]. 2016 [cited 2020 Feb 18]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/programa-nal-salud-visual-2016.pdf 6. Health Organization W. World report on vision [Internet]. 2019 [cited 2020 Aug 22]. Available from: https://apps.who.int/iris/bitstream/handle/10665/328717/9789241516570-eng.pdf 7. Khawaja AP, Sherratt MA, Sparrow JM. The Royal College of Ophthalmologists’ Glaucoma Commissioning Guidance: Executive summary [Internet]. Vol. 31, Eye (Basingstoke). Nature Publishing Group; 2017 [cited 2020 Sep 3]. p. 818–22. Available from: www.nature.com/eye 8. Khawaja AP, Sherratt MA, Sparrow JM. Table 2 Experience, qualifications and competencies of the HCP involved in the care pathways for OHT, suspected glaucoma and glaucoma [Internet]. Eye (Basingstoke). 2017 [cited 2020 Sep 3]. p. 1–1. Available from: https://www.nature.com/articles/eye201711/tables/2 9. Diez RC, Roman JJ, Barbosa MJI. Concept of suspected open-angle glaucoma: Definition, diagnosis and treatment. Rev Mex Oftalmol. 2014 Oct 1;88(4):153–60. 10. Herrera D, Flores M. Implementation of applied techniques for the identification and prevention of Glaucoma through the use of medical imagesand specialized software [Internet]. [Cuenca]: Salesian Polytechnic University Cuenca Headquarters; 2016 [cited 2020 Sep 5]. Available from: https://dspace.ups.edu.ec/bitstream/123456789/12674/1/UPS-CT006488.pdf Universidades R. Brief Guide to Eye Health [Internet]. 2017 Nov [cited 2020 May 3]. Available from: https://web.ua.es/es/universidad-saludable/documentos/doc-xarxa2017/guia-abreviada-de-salud-ocular.pdf 12. Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011 Oct;152(4):515–22. 13. Alfaro M. Latin American guide to primary open angle glaucoma [Internet]. 2019 [cited 2020 Mar 25]. Available from: https://www.iapb.org 14. Grigera DE, Mello PAA, Barbosa WL, Casiraghi JF, Grossmann RP, Peyret A. Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: Results of an online survey. Arq Bras Oftalmol. 2013;76(3):163–9. 15. Olushola O, Oluwatoni O, Omodele J, Anthony B, Gboyega A, Ugochi A-O, et al. Spectrum of Glaucoma Presentation in a Suburban Teaching Hospital in South Western Nigeria. [cited 2020 Mar 25]; Available from: www.hsj.gr/archive 16. Mansouri K, Medeiros FA, Weinreb RN. Global rates of glaucoma surgery. Graefe’s Arch Clin Exp Ophthalmol. 2013 Nov 26;251(11):2609–15. 17. Kerr NM, Kumar HK, Crowston JG, Walland MJ. Glaucoma laser and surgical procedure rates in Australia. Br J Ophthalmol [Internet]. 2016 Dec 1 [cited 2020 Aug 16];100(12):1686–91. Available from: https://bjo.bmj.com/content/100/12/1686 18. Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: Long-term outcome. Br J Ophthalmol. 2010 Nov 1;94(11):1478–82. 19. Salgado Paris JE, Castro Salas M. The elderly with glaucoma, an urgent need to promote self-care behavior. Cienc y Enferm [Internet]. 2008 [cited 2020 Aug 16];14(1):17–22. Available from: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-95532008000100003&lng=es&nrm=iso&tlng=n 20. claramunt J FN. Glaucoma and population in 2020. Gaceta [Internet]. 2016 Apr [cited 2020 Aug 15];6. Available from: https://www.researchgate.net/profile/Noelia_Mora/publication/330811780_Glaucoma_y_poblacion_en_2020/links/5c54b34a92851c22a3a1471d/Glaucoma-y-poblacion-en-2020.pdf 21. Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol [Internet]. 2006 Mar [cited 2020 Aug 16];90(3):262–7. Available from: /pmc/articles/PMC1856963/? report=abstract 22. Dates macro. Arabia Saudita: Economics and demographics 2020 | datosmacro.com [Internet]. 20AD [cited 2020 Aug 17]. p. 1. Available from: https://datosmacro.expansion.com/paises/arabia-saudita 23. Khandekar R, Chauhan D, Yasir ZH, Al-Zobidi M, Judaibi R, Edward DP. The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) – A community based survey. Saudi J Ophthalmol [Internet]. 2019 Oct 1 [cited 2020 Aug 17];33(4):332–7. Available from: https://www.sciencedirect.com/science/article/pii/S1319453418300080 24. Keel S, Xie J, Foreman J, Lee PY, Alwan M, Fahy ET, et al. Prevalence of glaucoma in the Australian National Eye Health Survey [Internet]. Vol. 103, British Journal of Ophthalmology. BMJ Publishing Group; 2019 [cited 2020 Aug 16]. p. 191–5. Available from: http://bjo.bmj.com/ 25. Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology [Internet]. 1998 Apr 1 [cited 2020 Aug 16];105(4):733–9. Available from: https://pubmed.ncbi.nlm.nih.gov/9544649/ 26. Landers J, Henderson T, Craig J. The prevalence of glaucoma in indigenous Australians within Central Australia: The Central Australian Ocular Health Study. Br J Ophthalmol [Internet]. 2012 Feb 1 [cited 2020 Aug 16];96(2):162–6. Available from: https://bjo.bmj.com/content/96/2/162 27. Baker H, Ratnarajan G, Harper RA, Edgar DF, Lawrenson JG. Effectiveness of UK optometric enhanced eye care services: a realist review of the literature. Ophthalmic Physiol Opt [Internet]. 2016 Sep 1 [cited 2020 Aug 23];36(5):545–57. Available from: http://doi.wiley.com/10.1111/opo.12312 28. Huang J, Hennessy MP, Kalloniatis M, Zangerl B. Implementing collaborative care for glaucoma patients and suspects in Australia [Internet]. Vol. 46, Clinical and Experimental Ophthalmology. Blackwell Publishing; 2018 [cited 2020 Aug 16]. p. 826–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231046/ 29. Banes MJ, Culham LE, Bunce C, Xing W, Viswanathan A, Garway-Heath D. Agreement between optometrists and ophthalmologists on clinical management decisions for patients with glaucoma. Br J Ophthalmol [Internet]. 2006 May [cited 2020 Aug 23];90(5):579–85. Available from: /pmc/articles/PMC1857057/? report=abstract 30. Gunn PJG, Marks JR, Konstantakopoulou E, Edgar DF, Lawrenson JG, Roberts SA, et al. Clinical effectiveness of the Manchester Glaucoma Enhanced Referral Scheme. Br J Ophthalmol [Internet]. 2019 Aug 1 [cited 2020 Aug 23];103(8):1066–71. Available from: /pmc/articles/PMC6678050/? report=abstract 31. Barrett C, O’Brien C, Loughman J. Glaucoma referral refinement in Ireland: managing the sensitivity-specificity paradox in optometric practice. Ophthalmic Physiol Opt [Internet]. 2018 Jul 1 [cited 2020 Aug 23];38(4):400–10. Available from: https://pubmed.ncbi.nlm.nih.gov/29492992/ 32. Nakazawa T. Aiming for zero blindness [Internet]. Vol. 119, Nippon Ganka Gakkai zasshi. Nippon Ganka Gakkai Zasshi; 2015 [cited 2020 Aug 23]. p. 168–94. Available from: https://pubmed.ncbi.nlm.nih.gov/25854109/ 33. Tanihara H, Kakuda T, Sano T, Kanno T, Imada R, Shingaki W, et al. Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study. Adv Ther [Internet]. 2019 Feb 1 [cited 2020 Aug 23];36(2):333–43. Available from: /pmc/articles/PMC6824384/? report=abstract 34. Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, et al. Additive intraocular pressure-lowering effects of the rho kinase inhibitor ripasudil (K-115) combined with timolol or latanoprost: A report of 2 randomized clinical trials. JAMA Ophthalmol [Internet]. 2015 Jul 1 [cited 2020 Aug 23];133(7):755–61. Available from: https://pubmed.ncbi.nlm.nih.gov/25880207/ 35. Al Owaifeer AM, Alrefaie SM, Alsawah ZM, Al Taisan AA, Mousa A, Ahmad SI. The effect of a short animated educational video on knowledge among glaucoma patients. Clin Ophthalmol [Internet]. 2018 May 1 [cited 2020 Aug 24]; 12:805–10. Available from: /pmc/articles/PMC5936007/? report=abstract 36. Quesada A. Congenital Glaucoma - SAERA Higher Education School [Internet]. 2018 [cited 2020 Aug 24]. Available from: https://www.saera.eu/glaucoma-congenito/ 37. Badawi AH, Al-Muhaylib AA, Al Owaifeer AM, Al-Essa RS, Al-Shahwan SA. Primary congenital glaucoma: An updated review [Internet]. Vol. 33, Saudi Journal of Ophthalmology. Elsevier B.V.; 2019 [cited 2020 Aug 24]. p. 382–8. Available from: /pmc/articles/PMC6950954/? report=abstract 38. Malik R, Khandekar R, Boodhna T, Rahbeeni Z, Al Towerki AE, Edward DP, et al. Eradicating primary congenital glaucoma from Saudi Arabia: The case for a national screening program [Internet]. Vol. 31, Saudi Journal of Ophthalmology. Elsevier B.V.; 2017 [cited 2020 Aug 24]. p. 247–9. Available from: /pmc/articles/PMC5717496/? report=abstract 39. Bernal GB, General S, Gómez FR, Valderrama JF. Guidelines for the implementation of activities to promote visual health, control of visual disturbances and avoidable visual impairment (Vision 2020 Strategy) [Internet]. 2017 [cited 2020 Sep 12]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/lineamientos-salud-visual-2017.pdf 40. Pardo M, Agudelo C. Guide for the early detection of visual disturbances and ocular pathologies [Internet]. Support program for social protection. [cited 2020 Sep 5]. p. 1–30. Available from: http://www.hmgy.gov.co/publicaciones/1. GUIA 5.pdf 41. Muñoz A, Montoya Gloryt. Acute angle-closure glaucoma: Emergency management by the optometrist - Dialnet. Cienc Tecnol salud Vis Ocul [Internet]. 2014 Jun [cited 2020 Sep 7];12(No 1):1–10. Available from: file:///C:/Users/USUARIO/Downloads/Dialnet-GlaucomaAgudoPorCierreAngular-5599378.pdf 42. Ministry of Health. Ministry of Health: Resolution number 00412 of 2000 [Internet]. Health service in Colombia. 2020 [cited 2020 Sep 5]. p. 1–1. Available from: http://www.saludcolombia.com/actual/htmlnormas/Res412_00.htm 43. Malagon E, Ñustes E, Martínez A, Urrego P. Primary open angle glaucoma: evaluation of the quality of clinical practice guidelines from Colombia, México, Chile y Spain [Internet]. Bogota; 2019 [cited 2020 Sep 5]. Available from: https://ciencia.lasalle.edu.co/optometriahttps://ciencia.lasalle.edu.co/optometria/369 | es_ES |
| dc.description.degreename | Optómetra | es_ES |
| dc.description.degreelevel | Pregrado | es_ES |
| dc.publisher.faculty | Facultad de Optometría | es_ES |
| dc.description.notes | Virtual | es_ES |
| dc.creator.cedula | 1013680707 | es_ES |
| dc.publisher.campus | Bogotá - Circunvalar | - |
| Aparece en las colecciones: | Optometría | |
Ficheros en este ítem:
| Fichero | Tamaño | |
|---|---|---|
| 2020AnaDanielaRomeroChia.pdf | 582.19 kB | Visualizar/Abrir |
| 2020AutorizaciondeAutores.pdf Restricted Access | 78.61 kB | Visualizar/Abrir Request a copy |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons
